Legis Daily

Access to Prescription Digital Therapeutics Act of 2022

USA117th CongressS-3791| Senate 
| Updated: 3/10/2022
Shelley Moore Capito

Shelley Moore Capito

Republican Senator

West Virginia

Cosponsors (3)
Jeanne Shaheen (Democratic)Marsha Blackburn (Republican)Cory A. Booker (Democratic)

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Access to Prescription Digital Therapeutics Act of 2022 This bill provides for Medicare and Medicaid coverage of prescription digital therapeutics (i.e., software applications that are used to prevent, manage, or treat medical conditions). The Centers for Medicare & Medicaid Services must establish a Medicare payment methodology for payments to manufacturers that takes into account certain factors (e.g., ongoing use); manufacturers must report specified information about private payors, subject to civil penalties.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 10, 2022

Latest Companion Bill Action

HR 117-7051
Referred to the Subcommittee on Health.
Mar 10, 2022
Introduced in Senate
Mar 10, 2022
Read twice and referred to the Committee on Finance.
  • March 10, 2022

    Latest Companion Bill Action

    HR 117-7051
    Referred to the Subcommittee on Health.


  • March 10, 2022
    Introduced in Senate


  • March 10, 2022
    Read twice and referred to the Committee on Finance.

Health

Related Bills

  • HR 117-7051: Access to Prescription Digital Therapeutics Act of 2022
Business recordsCivil actions and liabilityComputers and information technologyDigital mediaHealth care costs and insuranceInternet, web applications, social mediaMedicaidMedicarePrescription drugs

Access to Prescription Digital Therapeutics Act of 2022

USA117th CongressS-3791| Senate 
| Updated: 3/10/2022
Access to Prescription Digital Therapeutics Act of 2022 This bill provides for Medicare and Medicaid coverage of prescription digital therapeutics (i.e., software applications that are used to prevent, manage, or treat medical conditions). The Centers for Medicare & Medicaid Services must establish a Medicare payment methodology for payments to manufacturers that takes into account certain factors (e.g., ongoing use); manufacturers must report specified information about private payors, subject to civil penalties.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 10, 2022

Latest Companion Bill Action

HR 117-7051
Referred to the Subcommittee on Health.
Mar 10, 2022
Introduced in Senate
Mar 10, 2022
Read twice and referred to the Committee on Finance.
  • March 10, 2022

    Latest Companion Bill Action

    HR 117-7051
    Referred to the Subcommittee on Health.


  • March 10, 2022
    Introduced in Senate


  • March 10, 2022
    Read twice and referred to the Committee on Finance.
Shelley Moore Capito

Shelley Moore Capito

Republican Senator

West Virginia

Cosponsors (3)
Jeanne Shaheen (Democratic)Marsha Blackburn (Republican)Cory A. Booker (Democratic)

Finance Committee

Health

Related Bills

  • HR 117-7051: Access to Prescription Digital Therapeutics Act of 2022
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business recordsCivil actions and liabilityComputers and information technologyDigital mediaHealth care costs and insuranceInternet, web applications, social mediaMedicaidMedicarePrescription drugs